Related Experiment Video
Updated: May 11, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity
C Zucchini1, M C Manara2, R S Pinca2
1Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Re-expressing CD99wt in osteosarcoma inhibits metastasis by strengthening cell-cell contacts and blocking migration pathways. This involves inhibiting ROCK2 signaling, increasing N-cadherin and β-catenin at the membrane, and reducing ezrin.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- CD99 (MIC2 gene) is a transmembrane protein involved in cell adhesion, migration, and apoptosis.
- In osteosarcoma, CD99 acts as a tumor suppressor, with distinct roles for full-length (CD99wt) and short-form (CD99sh) proteins in malignancy.
- Osteosarcoma metastasis involves complex changes in cell-cell contacts, actin cytoskeleton, and signaling pathways.
Purpose of the Study:
- To identify molecular mechanisms underlying osteosarcoma metastasis by comparing cells with varying metastasis capabilities and CD99 expression.
- To evaluate how CD99wt influences cell-cell contacts, actin cytoskeleton organization, and signaling pathways in osteosarcoma.
Main Methods:
- Comparative analysis of osteosarcoma cells with different metastatic potential and CD99 expression levels.
- Forced expression (transfection) of CD99wt in osteosarcoma cells.
- Assessment of protein localization (N-cadherin, β-catenin, ezrin) and expression of cytoskeletal regulators (ACTR2, ARPC1A, ROCK2).
- Investigation of signaling pathways involving c-Src and ROCK2.
Main Results:
- Forced CD99wt expression promoted N-cadherin and β-catenin recruitment to adherens junctions.
- CD99wt transfection inhibited expression of ACTR2, ARPC1A, ROCK2, and ezrin, key regulators of actin cytoskeleton remodeling.
- CD99wt inhibited ROCK2 signaling by maintaining c-Src in an inactive state, reducing membrane ezrin and increasing membrane N-cadherin/β-catenin.
- ROCK2 was identified as a critical mediator of osteosarcoma cell migration.
Conclusions:
- Re-expression of CD99wt in osteosarcoma increases cell-cell contact strength and reactivates stop-migration signals.
- CD99wt counteracts the pro-migratory role of ezrin by inhibiting c-Src and ROCK2 activity, thereby reducing metastasis.
- CD99wt functions as a tumor suppressor in osteosarcoma by modulating cell adhesion and cytoskeletal dynamics to inhibit migration.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
